Therapy for pediatric brain tumors and the risk of growth hormone deficiency

Journal of Clinical Oncology

Volumn 29, Issue 36, 2011, Pages 4743-4744

  Sklar, Charles ^a   Wolden, Suzanne ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; GROWTH HORMONE; LEVODOPA; RECOMBINANT GROWTH HORMONE;

BODY FAT; BODY MASS; BONE DENSITY; BRAIN RADIATION; BRAIN TUMOR; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER SURGERY; CHILDHOOD CANCER; CRANIOPHARYNGIOMA; DISEASE COURSE; DYSLIPIDEMIA; EDITORIAL; EXTERNAL BEAM RADIOTHERAPY; GERM CELL TUMOR; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; HORMONE SUBSTITUTION; HUMAN; HYPOPHYSIS; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INSULIN RESISTANCE; MEDULLOBLASTOMA; MUSCLE MASS; MUSCLE STRENGTH; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NERVE GLIOMA; PRIORITY JOURNAL; RADIATION DOSE; RADIATION FIELD; RADIATION INJURY;

BRAIN NEOPLASMS; CRANIAL IRRADIATION; HUMAN GROWTH HORMONE; HUMANS; RADIOTHERAPY, CONFORMAL;

EID: 84555190796     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2011.38.9833     Document Type: Editorial

References (14)

1. Chemaitilly W, Sklar CA: Endocrine complications in long-term survivors of childhood cancers. Endocr Relat Cancer 17:R141-R159, 2010
2. Sklar CA, Constine LS: Chronic neuroendocrinological sequelae of radiation therapy. Int J Radiat Oncol Biol Phys 31:1113-1121, 1995
3. Chemaitilly W, Sklar CA: Endocrine complications of hematopoietic stem cell transplantation. Endocrinol Metab Clin North Am 36:983-998, 2007 (Pubitemid 350026254)
4. Growth Hormone Research Society: Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: Summary statement of the GH Research Society. J Clin Endocrinol Metab 85:3990-3993, 2000
5. Stanley TL, Levitsky LL, Grinspoon SK, et al.: Effect of body mass index on peak growth hormone response to provocative testing in children with short stature. J Clin Endocrinol Metab 94:4875-4881, 2009
6. Thomas JD, Monson JP: Adult GH deficiency throughout lifetime. Eur J Endocrinol 161:S97-S106, 2009 (suppl 1)
7. Bell J, Parker KL, Swinford RD, et al.: Long-term safety of recombinant human growth hormone in children. J Clin Endocrinol Metab 95:167-177, 2010
8. Mackenzie S, Craven T, Gattamaneni HR, et al.: Long-term safety of growth hormone replacement after CNS irradiation. J Clin Endocrinol Metab 96:2756-2761, 2011
9. Ergun-Longmire B, Mertens AC, Mitby P, et al.: Growth hormone treatment and risk of second neoplasms in the childhood cancer survivor. J Clin Endocrinol Metab 91:3494-3498, 2006 (Pubitemid 44402126)
10. Merchant TE, Rose SR, Bosley C, et al.: Growth hormone secretion after conformal radiation therapy in pediatric patients with localized brain tumors. J Clin Oncol 29:4776-4780, 2011
11. Lissett CA, Saleem S, Rahim A, et al.: The impact of irradiation on growth hormone responsiveness to provocative agents is stimulus dependent: Results in 161 individuals with radiation damage to the somatotropic axis. J Clin Endocrinol Metab 86:663-668, 2001 (Pubitemid 32207478)
12. Gondi V, Tomé WA, Mehta MP: Why avoid the hippocampus? A comprehensive review. Radiother Oncol 97:370-3766, 2010
13. Polkinghorn WR, Dunkel IJ, Souweidane MM, et al.: Disease control and ototoxicity using intensity-modulated radiation therapy tumor-bed boost for medulloblastoma. Int J Radiat Oncol Biol Phys [epub ahead of print on April 9, 2011]
14. Haddy N, Mousannif A, Tukenova M, et al.: Relationship between the brain radiation dose for the treatment of childhood cancer and the risk of long-term cerebrovascular mortality. Brain 134:1362-1372, 2011